Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF is an ETF issued by Invesco Ltd. on Jun 23 2005. The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care". As of today, the price of PBE ETF according to its net asset value is premiumed at 0.05%. While the total value of the fund shows $-2,253,445 decrease compared to the previous month, its price is traded daily at a increase of 0.01%. The annual dividend yield of PBE ETF is 0.24%, whereas its main asset area is North America. PBE ETF, whose 24-hour total volume is $11.45K, has experienced a $-13,872,010 cash outflow in the last month. In addition, Invesco Biotechnology & Genome ETF's 3-month net asset value total return is 7.80%.